Skip to content

Use of ayurvedic drug in the management of urinary infection.

Randomised control study of ayurvedic formulation (Madhukadighana vati) in the management of mootrakrichchhra (Urinary tract infection). - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056345
Enrollment
100
Registered
2023-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

Keshav ayurvedic medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of Mootrakrichchhra according to classical sign and symptoms with positive urine microscopy and urine culture. 2.Age- 16 to 70 years (Madhayma Ayu according to Acharya Sushruta-Su.Su.35/35) 3.Sex- Both, male and female

Exclusion criteria

Exclusion criteria: 1.Age- below 16 years and above 70 years patient. 2.Genital Herpes. 3.Cancer patients (like-vaginal, uterine, bladder). 4.Tuberculosis affecting the any part of urinary system like- Bladder TB. 5.Uncontrolled Diabetes Mellitus 6.Subjects with ARF and CRF 7.Subjects with Venereal Diseases 8.HIV & HBsAg and Anti-HIV positive subjects 9.Any associated bleeding disorder or sign of any severe illness 10.Patient suffering from diseases such as Hepatic, CVS, CNS, Respiratory and Haematological disorders.

Design outcomes

Primary

MeasureTime frame
To evaluate the clinical efficacy of ayurvedic compound in the management of mootrakrichchhra (Urinary Tract Infection).Timepoint: Every 15th day from the baseline up to 60 days

Secondary

MeasureTime frame
Primary objectives To analyse the mootrakrichchhra on the basis of textual reference in brihatraye as well as contemporary medical science. Secondary objectives 2.To provide cheap, safe & effective treatment in UTI. Timepoint: From baseline

Countries

India

Contacts

Public ContactDr. Geeta

DSRRAU, Jodhpur

guptadrrajeshkumargupta@gmail.com9636520573

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026